Get started
Author

Yuki Akazawa

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
2018 · Akio Osa, Takeshi Uenami, et al. · JCI Insight · 233
PDF
Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)
2020 · Ryoji Kato, Hidetoshi Hayashi, et al. · Journal for ImmunoTherapy of Cancer · 66
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report
2017 · Takeshi Uenami, Yuki Hosono, et al. · Lung Cancer · 51
Case series of pleomorphic carcinomas of the lung treated with nivolumab
2017 · Masaki Kanazu, Takeshi Uenami, et al. · Thoracic Cancer · 50
Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study
2020 · Yuji Yamamoto, Yukihiro Yano, et al. · Thoracic Cancer · 41
PDF
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)
2018 · Motoko Tachihara, Shunichi Negoro, et al. · BMC Cancer · 41
PDF
Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series
2018 · Masaki Kanazu, Ryuya Edahiro, et al. · Thoracic Cancer · 29
PDF
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)
2021 · Yukari Tsubata, Kana Watanabe, et al. · International Journal of Clinical Oncology · 21
PDF
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report
2019 · Ryuya Edahiro, Mikako Ishijima, et al. · Thoracic Cancer · 18
Non‐small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune‐related adverse events in first‐line treatments with immune checkpoint inhibitors: A retrospective single‐center study
2022 · Yuki Akazawa, Aki Yoshikawa, et al. · Thoracic Cancer · 9
Mechanical Thrombectomy for Acute Middle Cerebral Artery Occlusion Caused by Tumor Embolism: A Case Report
2020 · Takuya Moriyama, Yuri Sugiura, et al. · Journal of Neuroendovascular Therapy · 9
PDF
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study
2018 · Yukihiro Yano, Hiroyuki Kurebe, et al. · PLoS ONE · 8
PDF
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer
2023 · Satoshi Igawa, Hiroki Yamamoto, et al. · Oncology · 7
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer
2022 · Masashi Kasajima, Satoshi Igawa, et al. · Oncology · 7
PDF
Small-cell lung carcinoma with long-term survival: A case report
2011 · Kazumi Nishino, Fumio Imamura, et al. · Oncology Letters · 7
PDF
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
2023 · Yuki Akazawa, Satoshi Igawa, et al. · Oncology · 6
Subacute Transient Encephalopathy Induced by Erlotinib
2011 · Takako Okyuama, Yuki Akazawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 6
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report
2021 · Tomoki Kuge, Fukuko Okabe, et al. · Thoracic Cancer · 5
A Retrospective Study of the Novel Combination of Paclitaxel and S1 for Pretreated Advanced Non-Small Cell Lung Cancer
2012 · Nana Aono, Yuri Ito, et al. · Chemotherapy · 5
Epstein–Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma
2011 · Toshinari Yagi, Jun Ishikawa, et al. · International Journal of Hematology · 5
Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression
2018 · Takeshi Uenami, Mikako Ishijima, et al. · Annals of Translational Medicine · 4
PDF
Endotracheal Bronchogenic Cyst
2011 · Takako Okuyama, Yuki Akazawa, et al. · Journal of Bronchology & Interventional Pulmonology · 3
EGFR ‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib
2021 · Reina Hara, Masaki Kanazu, et al. · Thoracic Cancer · 2
A phase II study to evaluate abscopal effect by palliative radiation therapy in nivolumab treatment for pretreated non-small cell lung cancer (HANSHIN 0116)
2019 · A. Hata, M. Satouchi, et al. · Annals of Oncology · 2
PDF
EP1.01-13 A Phase 2 Trial Assessing Osimertinib Activity Against Leptomeningeal Carcinomatosis in EGFR-Mutant Lung Cancer
2019 · Y. Akazawa, S. Nanjo, et al. · Journal of Thoracic Oncology · 2
PDF
Works count: 63
Citation count: 649
H-index: 9
I10-index: 9
Year
Topic
Type